Page last updated: 2024-12-05

phlorhizin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID6072
CHEMBL ID245067
CHEBI ID8113
SCHEMBL ID17290
MeSH IDM0016615

Synonyms (101)

Synonym
BRD-K73756878-001-02-9
nsc-2833
phlorizoside
phlorrhizin
DIVK1C_006421
KBIO1_001365
SDCCGMLS-0066626.P001
BSPBIO_002674
SPECTRUM4_001651
SPECTRUM_001291
einecs 200-487-1
1-propanone, 1-(2-(beta-d-glucopyranosyloxy)-4,6-dihydroxyphenyl)-3-(4-hydroxyphenyl)-
nsc 2833
3,5-dihydroxy-2-[3-(4-hydroxyphenyl)propanoyl]phenyl beta-d-glucopyranoside
CHEBI:8113 ,
SPECTRUM5_000521
1-[2,4-dihydroxy-6-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-phenyl]-3-(4-hydroxyphenyl)propan-1-one
1-[2-(.beta.-d-glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-1-propanone
phlorrhizen
ai3-19835
1-propanone, 1-[2-(beta-d-glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-
1-[2-(beta-d-glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-1-propanone
2'-(.beta.-d-glucopyranosyloxy)-4',6'-dihydroxy-3-(4-hydroxyphenyl)propiophenone
phloridzosid
2'-(beta-d-glucopyranosyloxy)-4',6'-dihydroxy-3-(4-hydroxyphenyl)propiophenone
4,6-dihydroxy-2-(beta-d-glucosido)-beta-(p-hydroxyphenyl)propiophenone
phloretin-2'-beta-glucoside
floridzin
phloretin 2'-glucoside
jmc511145 compound 1
bdbm20875
1-(2,4-dihydroxy-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-3-(4-hydroxyphenyl)propan-1-one
chembl245067 ,
o-glucoside, 1
phloridzin
phlorizin ,
60-81-1
C01604
phlorhizin
NCGC00142423-01
KBIO3_002174
KBIO2_001771
KBIO2_006907
KBIOGR_002141
KBIOSS_001771
KBIO2_004339
SPBIO_000881
SPECTRUM2_000701
SPECTRUM3_001227
SPECPLUS_000325
SPECTRUM300547
NCGC00142423-02
HMS2090P10
phloretin 2'-o-glucoside
P0248
1-[2,4-dihydroxy-6-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-(4-hydroxyphenyl)propan-1-one
A836937
1-[2,4-dihydroxy-6-[3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-phenyl]-3-(4-hydroxyphenyl)propan-1-one dihydrate;phlorizin dihydrate
1-{6-[(2s,4s,5s,3r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)(2h-3,4,5,6-tetrahydr opyran-2-yloxy)]-2,4-dihydroxyphenyl}-3-(4-hydroxyphenyl)propan-1-one
AKOS015920054
CCG-38341
phloretin 2'-ss-d-glucopyranoside
1-[2-(ss-d-glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-1-propanone
unii-cu9s17279x
phloretin-2'-o-beta-glucoside
cu9s17279x ,
phloridzinum
phloridzin [who-dd]
1-propanone, 1-(2-(.beta.-d-glucopyranosyloxy)-4,6-dihydroxyphenyl)-3-(4-hydroxyphenyl)-
phloridzinum [hpus]
phloridzin [mi]
phloridzin [inci]
phloretin-2'-o-.beta.-glucoside
S2343
gtpl4757
HY-N0143
CS-2013
SCHEMBL17290
1-[2-(?-d-glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-1-propanone
Q-100699
1-propanone, 1-[2-(.beta.-d-glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-
1-(2,4-dihydroxy-6-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)phenyl)-3-(4-hydroxyphenyl)propan-1-one
DTXSID3075339 ,
phlorizin (phloridzin)
SR-01000781913-2
SR-01000781913-5
SR-01000781913-4
sr-01000781913
AC-7976
lopin
Q413105
112318-65-7
AS-15724
phlorizin (dihydrate)
1-(2,4-dihydroxy-6-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)phenyl)-3-(4-hydroxyphenyl)propan-1-one
1-propanone,1-[2-(b-d-glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-
NCGC00142423-06
A868885
phloridzin1535
dtxcid1042738
phloridzin phenolic

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"Since the Gulf war exposure to depleted uranium, a known nephrotoxic agent, there is a renewed interest in the toxic effects of uranium in general and its mechanism of nephrotoxicity which is still largely unknown in particular."( Nephrotoxicity of uranyl acetate: effect on rat kidney brush border membrane vesicles.
Cohen-Luria, R; Doshnitzki, Z; Goldman, M; Moran, A; Yaari, A, 2006
)
0.33
" Intense research has identified a number of genetic variants that may predispose to impaired B-cell function, but such predisposition can be precipitated and worsened by toxic effects of hyperglycaemia (glucotoxicity) and elevated levels of free fatty acids (lipotoxicity)."( Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies.
Del Prato, S, 2009
)
0.35
" Consequently, the direct toxic effects in the kidney and the gastric dilatation were resolved without interfering with the β-cell toxicity."( Phlorizin pretreatment reduces acute renal toxicity in a mouse model for diabetic nephropathy.
Brouwers, B; Cauwelier, EJG; Creemers, JWM; Declercq, J; Ectors, N; Lerut, E; Pruniau, VPEG; Schuit, F, 2013
)
0.39

Pharmacokinetics

ExcerptReferenceRelevance
"A pharmacokinetic and pharmacodynamic (PK-PD) model for the inhibitory effect of sodium-glucose cotransporter (SGLT) inhibitors on renal glucose reabsorption was developed to predict in vivo efficacy."( Pharmacokinetic and pharmacodynamic modeling of the effect of an sodium-glucose cotransporter inhibitor, phlorizin, on renal glucose transport in rats.
Asanuma, K; Aso, Y; Ikeda, S; Ishigai, M; Kato, M; Suzuki, M; Yamaguchi, K, 2011
)
0.37
" Compared with the observations for normal rats, AUC0-t and Cmax of PHZ significantly increased and T1/2 of PHZ significantly decreased in T2D rats."( Comparative oral and intravenous pharmacokinetics of phlorizin in rats having type 2 diabetes and in normal rats based on phase II metabolism.
Fang, M; Gao, Z; Hu, H; Jia, L; Li, Q; Wang, A; Wang, Z; Yi, K; Zhang, X, 2019
)
0.51
" Here, we report metabolites and pharmacokinetic parameters of PZ-DHA, determined using ultra-high-performance liquid chromatography-electrospray ionization tandem mass spectrometry."( Metabolism and pharmacokinetics of a novel polyphenol fatty acid ester phloridzin docosahexaenoate in Balb/c female mice.
Fernando, W; Goralski, KB; Hoskin, DW; Rupasinghe, HPV, 2020
)
0.56
" The pharmacokinetic profile, metabolites of the PRZ, and efficacy of metabolites towards SGLTs are unknown."( A pharmacokinetic study to correlate the hypoglycemic effect of phlorizin in rats: Identification of metabolites as inhibitors of sodium/glucose cotransporters.
Agarwal, SM; Banerjee, SK; Borkar, RM; Das, AP; Kanwal, A; Pulimamidi, SS; Raju, B; Srinivas, R, 2023
)
0.91

Bioavailability

ExcerptReferenceRelevance
"34 microL/min/cm, mean +/- SE, N = 4), calculated by dividing the absorption rate by the drug concentration, was significantly decreased (0."( Intestinal active absorption of sugar-conjugated compounds by glucose transport system: implication of improvement of poorly absorbable drugs.
Awazu, S; Hayashi, M; Mizuma, T; Ohta, K, 1992
)
0.28
"1 g C/d) was approximately three times the estimated rate of absorption of exogenous threonine (1 g C/d)."( Threonine metabolism in sheep. I. Threonine catabolism and gluconeogenesis in mature Blackface wethers given poor quality hill herbage.
Egan, AR; Lamb, CS; MacRae, JC, 1983
)
0.27
" F-X enhanced D-xylose absorption rate in rat everted intestinal sac."( Studies on mechanisms of diarrhea induced by fusarenon-X, a trichothecene mycotoxin from Fusarium species; characteristics of increased intestinal absorption rate induced by fusarenon-X.
Kubota, K; Matsuoka, Y, 1982
)
0.26
"To evaluate the role of Na(+)-glucose cotransport in fluid absorption across alveolar epithelial walls in isolated rat lungs, we measured the inhibitory effects of amiloride (a Na+ channel blocker) and phlorizin (a Na(+)-glucose cotrasport blocker) on the fluid absorption rate in fluid-filled lungs."( [Role of Na(+)-glucose cotransport in fluid absorption across alveolar epithelium in isolated rat lungs].
Fujimura, S; Koike, K; Noda, M; Ono, S; Sakuma, T; Sugita, M; Suzuki, S; Tanita, T, 1996
)
0.29
" High intakes and an adequate absorption rate of isoflavones are necessary for efficient chemoprevention, though other dietary agents might increase absorption efficacy."( Phloridzin improves absorption of genistin in isolated rat small intestine.
Andlauer, W; Fürst, P; Kolb, J, 2004
)
0.32
"In previous experiments, genistin absorption rate of 17."( Phloridzin improves absorption of genistin in isolated rat small intestine.
Andlauer, W; Fürst, P; Kolb, J, 2004
)
0.32
" A liquid chromatography-tandem mass spectrometry procedure was used to investigate the metabolism and bioavailability of puerarin and daidzin."( Contrasting effects of puerarin and daidzin on glucose homeostasis in mice.
Barnes, S; Jones, K; Meezan, E; Meezan, EM; Moore, R; Prasain, JK, 2005
)
0.33
" The poor oral bioavailability and adverse effects associated with this agent, however, have prevented its use in clinical practice and restricted its use to that of a physiological tool."( Renal glucose transporters: novel targets for hyperglycemia management.
Mather, A; Pollock, C, 2010
)
0.36
" While a few studies have been conducted to evaluate the bioavailability of anthocyanins, the mechanisms of their absorption mechanism remain ill-defined."( The role of sodium-dependent glucose transporter 1 and glucose transporter 2 in the absorption of cyanidin-3-o-β-glucoside in Caco-2 cells.
Feng, D; Li, HW; Ling, WH; Song, G; Tang, HW; Zou, TB, 2014
)
0.4
" [14C]Luseogliflozin was rapidly and well absorbed (>86% of the dose) after oral administration to rats and dogs."( Preclinical metabolism and disposition of luseogliflozin, a novel antihyperglycemic agent.
Chino, Y; Fukasawa, Y; Hachiuma, K; Hasegawa, M; Horiuchi, N; Ishida, M; Nakai, Y; Yamaguchi, J, 2015
)
0.42
" Phloretin bioavailability is well known in humans, but still remains to be better studied in experimental animals, such as mouse and rat."( Phloretin-induced cytoprotective effects on mammalian cells: A mechanistic view and future directions.
de Oliveira, MR,
)
0.13
" The system recorded currents relative to glucose (1mM) absorption, obtaining bioavailability values (5."( Real-time monitoring of glucose and phenols intestinal absorption through an integrated Caco-2TC7cells/biosensors telemetric device: Hypoglycemic effect of fruit phytochemicals.
Barberis, A; Bazzu, G; Cardinali, A; D'Antuono, I; D'Hallewin, G; Fadda, A; Garbetta, A; Linsalata, V; Minervini, F; Rocchitta, G; Serra, PA, 2017
)
0.46
" The absorption rate constant (Ka) and the apparent absorption coefficient(Papp)of phloridzin decreased following the sequence of jejunum> colon > duodenum > ileum."( [In vivo intestinal absorption characteristics of phloridzin in rats].
Fan, Y; Guo, DY; Li, J; Shi, YJ; Yang, WP; Zhai, BT, 2016
)
0.43
" Like other flavonoids, the bioavailability challenge of PHZ is the wide phase I and II metabolism in the digestive tract."( Comparative oral and intravenous pharmacokinetics of phlorizin in rats having type 2 diabetes and in normal rats based on phase II metabolism.
Fang, M; Gao, Z; Hu, H; Jia, L; Li, Q; Wang, A; Wang, Z; Yi, K; Zhang, X, 2019
)
0.51
" PHZ was firstly identified as a competitive inhibitor of sodium-glucose co-transporters-2 (SGLT2); however, its low bioavailability makes it hard to fully explain its pharmacological mechanisms."( Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity.
Chen, J; Gou, X; Peng, L; Peng, T; Tang, L; Xie, J; Yi, K; Zhang, XY, 2020
)
0.56
" However, the limited cellular uptake and bioavailability restrict their clinical use."( Metabolism and pharmacokinetics of a novel polyphenol fatty acid ester phloridzin docosahexaenoate in Balb/c female mice.
Fernando, W; Goralski, KB; Hoskin, DW; Rupasinghe, HPV, 2020
)
0.56
" As a kind of aglycons, phloretin (PHT) possesses a better bioavailability and bioactivity than PHZ."( Biotransformation of Phlorizin by Eurotium cristatum to Increase the Antioxidant and Antibacterial Activity of Docynia indica Leaves.
Chen, J; Du, J; Li, XL; Mei, XR; Xie, J; Zhang, XY; Zhu, MJ, 2021
)
0.62
" PZ-DHA is more stable than DHA and exhibits higher cellular uptake and bioavailability than PZ."( Docosahexaenoic Acid Ester of Phloridzin Reduces Inflammation and Insulin Resistance
Chen, J; Dong, Q; Qiu, Y; Si, X; Sun, T; Wang, J; Wu, W; Wu, Z; Zhang, R, 2022
)
0.72
" This study confirmed the potential applications of CDs as molecular stabilizers and aqueous solubilizers for the improved bioavailability and efficient delivery of food bioactive compounds."( How cyclodextrin encapsulation improves molecular stability of apple polyphenols phloretin, phlorizin, and ferulic acid: Atomistic insights through structural chemistry.
Aree, T, 2023
)
0.91

Dosage Studied

ExcerptRelevanceReference
" Dose-response curves of sperm motility in the additions of glucose or fructose were bell-shaped."( Studies on the effects of sugars on washed human sperm motility.
Moriwaki, C; Nagai, T; Yamaguchi, K, 1982
)
0.26
" The in vitro insulin dose-response curves of tyrosine kinase activity showed no significant differences between insulin-infused and control rats."( Regulation of rat insulin receptor tyrosine kinase by hypoglycemia.
Buongiorno, A; Caiola, S; D'Adamo, M; Giaccari, A; Leonetti, F; Morviducci, L; Sbraccia, P; Tamburrano, G; Zorretta, D, 1994
)
0.29
" The dose-response curve was an inverted-U shape."( Phlorizin, a competitive inhibitor of glucose transport, facilitates memory storage in mice.
Baratti, CM; Boccia, MM; Kopf, SR, 1999
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
aryl beta-D-glucoside
dihydrochalconesAny ketone that is 1,3-diphenylpropanone and its derivatives obtained by substitution.
monosaccharide derivativeA carbohydrate derivative that is formally obtained from a monosaccharide.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
phloridzin biosynthesis212

Protein Targets (16)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
PPM1D proteinHomo sapiens (human)Potency9.30050.00529.466132.9993AID1347411
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency35.48130.001815.663839.8107AID894
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency0.31620.251215.843239.8107AID504327
Interferon betaHomo sapiens (human)Potency9.30050.00339.158239.8107AID1347411
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sodium/nucleoside cotransporter 1Homo sapiens (human)IC50 (µMol)250.00005.50005.65005.8000AID370696
Sodium/nucleoside cotransporter 2Homo sapiens (human)IC50 (µMol)550.00005.50005.50005.5000AID1205658; AID370697
Pancreatic triacylglycerol lipaseSus scrofa (pig)IC50 (µMol)300.00000.00401.10246.5000AID1464929
Sodium/glucose cotransporter 1Homo sapiens (human)IC50 (µMol)15.62050.06071.61058.4440AID1076410; AID1436776; AID1546222; AID1721967; AID295285; AID443605; AID462407; AID475685; AID589966; AID614607; AID670284; AID695389; AID703959
Sodium/glucose cotransporter 1Homo sapiens (human)Ki0.18000.18003.86007.5400AID205450
Sodium/glucose cotransporter 2Homo sapiens (human)IC50 (µMol)7.79550.00050.16534.1000AID1076411; AID1436777; AID1546223; AID1559420; AID1721968; AID295286; AID348687; AID462408; AID475684; AID589965; AID670283; AID695390; AID703960
Sodium/glucose cotransporter 2Homo sapiens (human)Ki0.01860.01860.08480.1510AID418688
Bifunctional epoxide hydrolase 2Homo sapiens (human)IC50 (µMol)41.72000.00000.54509.1000AID1126472
Sodium/glucose cotransporter 1 Rattus norvegicus (Norway rat)IC50 (µMol)0.35000.35000.35000.3500AID695392
Sodium/glucose cotransporter 2Rattus norvegicus (Norway rat)IC50 (µMol)0.09600.00120.04860.0960AID695393
Equilibrative nucleoside transporter 1Homo sapiens (human)Ki1,000.00000.00040.10381.1000AID370699
Solute carrier family 28 member 3Homo sapiens (human)Ki16.00002.10002.75003.4000AID370698
Solute carrier family 5 member 4Homo sapiens (human)IC50 (µMol)0.01600.00090.06960.2600AID614606
Prostaglandin D2 receptor 2Homo sapiens (human)IC50 (µMol)0.06070.00040.10090.9600AID1076410
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sodium/glucose cotransporter 1Homo sapiens (human)EC50 (µMol)0.20090.00111.25448.3000AID1292293; AID1348754; AID1798018; AID318037; AID554362; AID779738
Sodium/glucose cotransporter 2Homo sapiens (human)EC50 (µMol)0.10180.00110.11071.3900AID1292292; AID1348753; AID1798018; AID318036; AID365408; AID365411; AID418688; AID554361; AID779739
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (96)

Processvia Protein(s)Taxonomy
cytidine transportSodium/nucleoside cotransporter 1Homo sapiens (human)
uridine transmembrane transportSodium/nucleoside cotransporter 1Homo sapiens (human)
azole transmembrane transportSodium/nucleoside cotransporter 1Homo sapiens (human)
pyrimidine-containing compound transmembrane transportSodium/nucleoside cotransporter 1Homo sapiens (human)
nucleoside import across plasma membraneSodium/nucleoside cotransporter 1Homo sapiens (human)
nucleoside transmembrane transportSodium/nucleoside cotransporter 1Homo sapiens (human)
purine nucleobase transmembrane transportSodium/nucleoside cotransporter 1Homo sapiens (human)
pyrimidine nucleobase transportSodium/nucleoside cotransporter 1Homo sapiens (human)
nucleobase-containing compound metabolic processSodium/nucleoside cotransporter 2Homo sapiens (human)
xenobiotic metabolic processSodium/nucleoside cotransporter 2Homo sapiens (human)
neurotransmitter transportSodium/nucleoside cotransporter 2Homo sapiens (human)
xenobiotic transmembrane transportSodium/nucleoside cotransporter 2Homo sapiens (human)
pyrimidine nucleobase transportSodium/nucleoside cotransporter 2Homo sapiens (human)
purine nucleoside transmembrane transportSodium/nucleoside cotransporter 2Homo sapiens (human)
uridine transmembrane transportSodium/nucleoside cotransporter 2Homo sapiens (human)
adenosine transportSodium/nucleoside cotransporter 2Homo sapiens (human)
inosine transportSodium/nucleoside cotransporter 2Homo sapiens (human)
azole transmembrane transportSodium/nucleoside cotransporter 2Homo sapiens (human)
pyrimidine-containing compound transmembrane transportSodium/nucleoside cotransporter 2Homo sapiens (human)
transport across blood-brain barrierSodium/nucleoside cotransporter 2Homo sapiens (human)
nucleoside transmembrane transportSodium/nucleoside cotransporter 2Homo sapiens (human)
purine nucleobase transmembrane transportSodium/nucleoside cotransporter 2Homo sapiens (human)
retina homeostasisSodium/nucleoside cotransporter 2Homo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
chloride transmembrane transportSodium/glucose cotransporter 1Homo sapiens (human)
glucose transmembrane transportSodium/glucose cotransporter 1Homo sapiens (human)
alpha-glucoside transportSodium/glucose cotransporter 1Homo sapiens (human)
intestinal D-glucose absorptionSodium/glucose cotransporter 1Homo sapiens (human)
response to inorganic substanceSodium/glucose cotransporter 1Homo sapiens (human)
pentose transmembrane transportSodium/glucose cotransporter 1Homo sapiens (human)
fucose transmembrane transportSodium/glucose cotransporter 1Homo sapiens (human)
galactose transmembrane transportSodium/glucose cotransporter 1Homo sapiens (human)
myo-inositol transportSodium/glucose cotransporter 1Homo sapiens (human)
transepithelial water transportSodium/glucose cotransporter 1Homo sapiens (human)
renal glucose absorptionSodium/glucose cotransporter 1Homo sapiens (human)
glucose import across plasma membraneSodium/glucose cotransporter 1Homo sapiens (human)
sodium ion import across plasma membraneSodium/glucose cotransporter 1Homo sapiens (human)
intestinal hexose absorptionSodium/glucose cotransporter 1Homo sapiens (human)
transport across blood-brain barrierSodium/glucose cotransporter 1Homo sapiens (human)
glucose transmembrane transportSodium/glucose cotransporter 1Homo sapiens (human)
sodium ion transportSodium/glucose cotransporter 1Homo sapiens (human)
alpha-glucoside transportSodium/glucose cotransporter 2Homo sapiens (human)
carbohydrate metabolic processSodium/glucose cotransporter 2Homo sapiens (human)
hexose transmembrane transportSodium/glucose cotransporter 2Homo sapiens (human)
renal glucose absorptionSodium/glucose cotransporter 2Homo sapiens (human)
glucose import across plasma membraneSodium/glucose cotransporter 2Homo sapiens (human)
sodium ion import across plasma membraneSodium/glucose cotransporter 2Homo sapiens (human)
sodium ion transportSodium/glucose cotransporter 2Homo sapiens (human)
response to toxic substanceBifunctional epoxide hydrolase 2Homo sapiens (human)
positive regulation of gene expressionBifunctional epoxide hydrolase 2Homo sapiens (human)
dephosphorylationBifunctional epoxide hydrolase 2Homo sapiens (human)
cholesterol homeostasisBifunctional epoxide hydrolase 2Homo sapiens (human)
stilbene catabolic processBifunctional epoxide hydrolase 2Homo sapiens (human)
phospholipid dephosphorylationBifunctional epoxide hydrolase 2Homo sapiens (human)
regulation of cholesterol metabolic processBifunctional epoxide hydrolase 2Homo sapiens (human)
epoxide metabolic processBifunctional epoxide hydrolase 2Homo sapiens (human)
neurotransmitter uptakeEquilibrative nucleoside transporter 1Homo sapiens (human)
nucleobase-containing compound metabolic processEquilibrative nucleoside transporter 1Homo sapiens (human)
xenobiotic metabolic processEquilibrative nucleoside transporter 1Homo sapiens (human)
neurotransmitter transportEquilibrative nucleoside transporter 1Homo sapiens (human)
xenobiotic transmembrane transportEquilibrative nucleoside transporter 1Homo sapiens (human)
lactationEquilibrative nucleoside transporter 1Homo sapiens (human)
nucleobase transportEquilibrative nucleoside transporter 1Homo sapiens (human)
adenine transportEquilibrative nucleoside transporter 1Homo sapiens (human)
nucleoside transportEquilibrative nucleoside transporter 1Homo sapiens (human)
purine nucleoside transmembrane transportEquilibrative nucleoside transporter 1Homo sapiens (human)
cytidine transportEquilibrative nucleoside transporter 1Homo sapiens (human)
uridine transmembrane transportEquilibrative nucleoside transporter 1Homo sapiens (human)
adenosine transportEquilibrative nucleoside transporter 1Homo sapiens (human)
inosine transportEquilibrative nucleoside transporter 1Homo sapiens (human)
hypoxanthine transportEquilibrative nucleoside transporter 1Homo sapiens (human)
thymine transportEquilibrative nucleoside transporter 1Homo sapiens (human)
excitatory postsynaptic potentialEquilibrative nucleoside transporter 1Homo sapiens (human)
cellular response to glucose stimulusEquilibrative nucleoside transporter 1Homo sapiens (human)
cellular response to hypoxiaEquilibrative nucleoside transporter 1Homo sapiens (human)
pyrimidine-containing compound transmembrane transportEquilibrative nucleoside transporter 1Homo sapiens (human)
transport across blood-brain barrierEquilibrative nucleoside transporter 1Homo sapiens (human)
nucleoside transmembrane transportEquilibrative nucleoside transporter 1Homo sapiens (human)
guanine transmembrane transportEquilibrative nucleoside transporter 1Homo sapiens (human)
uracil transmembrane transportEquilibrative nucleoside transporter 1Homo sapiens (human)
pyrimidine nucleobase transmembrane transportEquilibrative nucleoside transporter 1Homo sapiens (human)
purine nucleobase transmembrane transportEquilibrative nucleoside transporter 1Homo sapiens (human)
xenobiotic metabolic processSolute carrier family 28 member 3Homo sapiens (human)
xenobiotic transmembrane transportSolute carrier family 28 member 3Homo sapiens (human)
pyrimidine nucleobase transportSolute carrier family 28 member 3Homo sapiens (human)
uridine transmembrane transportSolute carrier family 28 member 3Homo sapiens (human)
sodium ion transmembrane transportSolute carrier family 28 member 3Homo sapiens (human)
pyrimidine-containing compound transmembrane transportSolute carrier family 28 member 3Homo sapiens (human)
nucleoside transmembrane transportSolute carrier family 28 member 3Homo sapiens (human)
purine nucleobase transmembrane transportSolute carrier family 28 member 3Homo sapiens (human)
pyrimidine nucleoside transportSolute carrier family 28 member 3Homo sapiens (human)
purine nucleoside transmembrane transportSolute carrier family 28 member 3Homo sapiens (human)
sodium ion transmembrane transportSolute carrier family 5 member 4Homo sapiens (human)
proton transmembrane transportSolute carrier family 5 member 4Homo sapiens (human)
sodium ion transportSolute carrier family 5 member 4Homo sapiens (human)
chemotaxisProstaglandin D2 receptor 2Homo sapiens (human)
immune responseProstaglandin D2 receptor 2Homo sapiens (human)
G protein-coupled receptor signaling pathwayProstaglandin D2 receptor 2Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathwayProstaglandin D2 receptor 2Homo sapiens (human)
calcium-mediated signalingProstaglandin D2 receptor 2Homo sapiens (human)
positive regulation of G protein-coupled receptor signaling pathwayProstaglandin D2 receptor 2Homo sapiens (human)
negative regulation of male germ cell proliferationProstaglandin D2 receptor 2Homo sapiens (human)
neuropeptide signaling pathwayProstaglandin D2 receptor 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (43)

Processvia Protein(s)Taxonomy
purine nucleobase transmembrane transporter activitySodium/nucleoside cotransporter 1Homo sapiens (human)
nucleoside:sodium symporter activitySodium/nucleoside cotransporter 1Homo sapiens (human)
cytidine transmembrane transporter activitySodium/nucleoside cotransporter 1Homo sapiens (human)
uridine transmembrane transporter activitySodium/nucleoside cotransporter 1Homo sapiens (human)
pyrimidine- and adenosine-specific:sodium symporter activitySodium/nucleoside cotransporter 1Homo sapiens (human)
azole transmembrane transporter activitySodium/nucleoside cotransporter 1Homo sapiens (human)
neurotransmitter transmembrane transporter activitySodium/nucleoside cotransporter 2Homo sapiens (human)
purine nucleobase transmembrane transporter activitySodium/nucleoside cotransporter 2Homo sapiens (human)
nucleoside:sodium symporter activitySodium/nucleoside cotransporter 2Homo sapiens (human)
purine nucleoside transmembrane transporter activitySodium/nucleoside cotransporter 2Homo sapiens (human)
uridine transmembrane transporter activitySodium/nucleoside cotransporter 2Homo sapiens (human)
pyrimidine- and adenosine-specific:sodium symporter activitySodium/nucleoside cotransporter 2Homo sapiens (human)
azole transmembrane transporter activitySodium/nucleoside cotransporter 2Homo sapiens (human)
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
galactose transmembrane transporter activitySodium/glucose cotransporter 1Homo sapiens (human)
glucose transmembrane transporter activitySodium/glucose cotransporter 1Homo sapiens (human)
myo-inositol:sodium symporter activitySodium/glucose cotransporter 1Homo sapiens (human)
water transmembrane transporter activitySodium/glucose cotransporter 1Homo sapiens (human)
glucose:sodium symporter activitySodium/glucose cotransporter 1Homo sapiens (human)
protein bindingSodium/glucose cotransporter 1Homo sapiens (human)
pentose transmembrane transporter activitySodium/glucose cotransporter 1Homo sapiens (human)
fucose transmembrane transporter activitySodium/glucose cotransporter 1Homo sapiens (human)
alpha-glucoside transmembrane transporter activitySodium/glucose cotransporter 1Homo sapiens (human)
galactose:sodium symporter activitySodium/glucose cotransporter 1Homo sapiens (human)
D-glucose transmembrane transporter activitySodium/glucose cotransporter 1Homo sapiens (human)
low-affinity glucose:sodium symporter activitySodium/glucose cotransporter 2Homo sapiens (human)
glucose:sodium symporter activitySodium/glucose cotransporter 2Homo sapiens (human)
protein bindingSodium/glucose cotransporter 2Homo sapiens (human)
alpha-glucoside transmembrane transporter activitySodium/glucose cotransporter 2Homo sapiens (human)
D-glucose transmembrane transporter activitySodium/glucose cotransporter 2Homo sapiens (human)
magnesium ion bindingBifunctional epoxide hydrolase 2Homo sapiens (human)
epoxide hydrolase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
toxic substance bindingBifunctional epoxide hydrolase 2Homo sapiens (human)
phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
lipid phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
protein homodimerization activityBifunctional epoxide hydrolase 2Homo sapiens (human)
lysophosphatidic acid phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
neurotransmitter transmembrane transporter activityEquilibrative nucleoside transporter 1Homo sapiens (human)
nucleoside transmembrane transporter activityEquilibrative nucleoside transporter 1Homo sapiens (human)
adenine transmembrane transporter activityEquilibrative nucleoside transporter 1Homo sapiens (human)
guanine transmembrane transporter activityEquilibrative nucleoside transporter 1Homo sapiens (human)
uracil transmembrane transporter activityEquilibrative nucleoside transporter 1Homo sapiens (human)
purine nucleoside transmembrane transporter activityEquilibrative nucleoside transporter 1Homo sapiens (human)
cytidine transmembrane transporter activityEquilibrative nucleoside transporter 1Homo sapiens (human)
uridine transmembrane transporter activityEquilibrative nucleoside transporter 1Homo sapiens (human)
pyrimidine- and adenosine-specific:sodium symporter activityEquilibrative nucleoside transporter 1Homo sapiens (human)
purine nucleobase transmembrane transporter activitySolute carrier family 28 member 3Homo sapiens (human)
nucleoside:sodium symporter activitySolute carrier family 28 member 3Homo sapiens (human)
protein bindingSolute carrier family 28 member 3Homo sapiens (human)
uridine transmembrane transporter activitySolute carrier family 28 member 3Homo sapiens (human)
purine-specific nucleoside:sodium symporter activitySolute carrier family 28 member 3Homo sapiens (human)
pyrimidine- and adenosine-specific:sodium symporter activitySolute carrier family 28 member 3Homo sapiens (human)
glucose:sodium symporter activitySolute carrier family 5 member 4Homo sapiens (human)
protein bindingSolute carrier family 5 member 4Homo sapiens (human)
proton transmembrane transporter activitySolute carrier family 5 member 4Homo sapiens (human)
prostaglandin J receptor activityProstaglandin D2 receptor 2Homo sapiens (human)
G protein-coupled receptor activityProstaglandin D2 receptor 2Homo sapiens (human)
prostaglandin D receptor activityProstaglandin D2 receptor 2Homo sapiens (human)
prostaglandin F receptor activityProstaglandin D2 receptor 2Homo sapiens (human)
neuropeptide bindingProstaglandin D2 receptor 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (23)

Processvia Protein(s)Taxonomy
cytosolSodium/nucleoside cotransporter 1Homo sapiens (human)
plasma membraneSodium/nucleoside cotransporter 1Homo sapiens (human)
apical plasma membraneSodium/nucleoside cotransporter 1Homo sapiens (human)
nuclear speckSodium/nucleoside cotransporter 1Homo sapiens (human)
brush border membraneSodium/nucleoside cotransporter 1Homo sapiens (human)
plasma membraneSodium/nucleoside cotransporter 1Homo sapiens (human)
plasma membraneSodium/nucleoside cotransporter 2Homo sapiens (human)
vesicle membraneSodium/nucleoside cotransporter 2Homo sapiens (human)
membraneSodium/nucleoside cotransporter 2Homo sapiens (human)
apicolateral plasma membraneSodium/nucleoside cotransporter 2Homo sapiens (human)
coated vesicleSodium/nucleoside cotransporter 2Homo sapiens (human)
brush border membraneSodium/nucleoside cotransporter 2Homo sapiens (human)
plasma membraneSodium/nucleoside cotransporter 2Homo sapiens (human)
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
early endosomeSodium/glucose cotransporter 1Homo sapiens (human)
plasma membraneSodium/glucose cotransporter 1Homo sapiens (human)
apical plasma membraneSodium/glucose cotransporter 1Homo sapiens (human)
brush border membraneSodium/glucose cotransporter 1Homo sapiens (human)
intracellular organelleSodium/glucose cotransporter 1Homo sapiens (human)
perinuclear region of cytoplasmSodium/glucose cotransporter 1Homo sapiens (human)
extracellular exosomeSodium/glucose cotransporter 1Homo sapiens (human)
intracellular vesicleSodium/glucose cotransporter 1Homo sapiens (human)
plasma membraneSodium/glucose cotransporter 1Homo sapiens (human)
plasma membraneSodium/glucose cotransporter 2Homo sapiens (human)
membraneSodium/glucose cotransporter 2Homo sapiens (human)
apical plasma membraneSodium/glucose cotransporter 2Homo sapiens (human)
extracellular exosomeSodium/glucose cotransporter 2Homo sapiens (human)
plasma membraneSodium/glucose cotransporter 2Homo sapiens (human)
peroxisomeBifunctional epoxide hydrolase 2Homo sapiens (human)
peroxisomal matrixBifunctional epoxide hydrolase 2Homo sapiens (human)
cytosolBifunctional epoxide hydrolase 2Homo sapiens (human)
extracellular exosomeBifunctional epoxide hydrolase 2Homo sapiens (human)
peroxisomeBifunctional epoxide hydrolase 2Homo sapiens (human)
plasma membraneEquilibrative nucleoside transporter 1Homo sapiens (human)
membraneEquilibrative nucleoside transporter 1Homo sapiens (human)
basolateral plasma membraneEquilibrative nucleoside transporter 1Homo sapiens (human)
apical plasma membraneEquilibrative nucleoside transporter 1Homo sapiens (human)
presynapseEquilibrative nucleoside transporter 1Homo sapiens (human)
postsynapseEquilibrative nucleoside transporter 1Homo sapiens (human)
plasma membraneEquilibrative nucleoside transporter 1Homo sapiens (human)
endoplasmic reticulum membraneSolute carrier family 28 member 3Homo sapiens (human)
plasma membraneSolute carrier family 28 member 3Homo sapiens (human)
brush border membraneSolute carrier family 28 member 3Homo sapiens (human)
plasma membraneSolute carrier family 28 member 3Homo sapiens (human)
plasma membraneSolute carrier family 5 member 4Homo sapiens (human)
plasma membraneProstaglandin D2 receptor 2Homo sapiens (human)
plasma membraneProstaglandin D2 receptor 2Homo sapiens (human)
neuron projectionProstaglandin D2 receptor 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (141)

Assay IDTitleYearJournalArticle
AID1232401Activity at mushroom tyrosinase assessed as decrease in absorbance using L-tyrosine as substrate by oxygen consumption assay2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Identification of p-hydroxybenzyl alcohol, tyrosol, phloretin and its derivate phloridzin as tyrosinase substrates.
AID462407Inhibition of alpha-D-[U-14C]glucopyranoside uptake at human SGLT1 expressed in african green monkey COS1 cells after 30 mins by liquid scintillation counting2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Alstiphyllanines E-H, picraline and ajmaline-type alkaloids from Alstonia macrophylla inhibiting sodium glucose cotransporter.
AID475684Inhibition of human SGLT2 expressed in CHOK1 cells assessed as inhibition of glucose uptake2010Journal of medicinal chemistry, Apr-22, Volume: 53, Issue:8
(1S)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-D-glucitol (TS-071) is a potent, selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for type 2 diabetes treatment.
AID378512Inhibition of concanavalin A-induced mouse T cells proliferation assessed as [3H]TdR incorporation at 1 uM by MTT assay2005Journal of natural products, Mar, Volume: 68, Issue:3
Dihydrochalcones from the leaves of Pieris japonica.
AID695399Antihyperglycemic activity in Wistar rat streptozotocin-nicotinamide-induced diabetic model assessed as reduction of plasma glucose level at 1 mg/kg, po after 1 hr by oral mixed carbohydrate tolerance test2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Structure-activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia.
AID1126472Inhibition of sEH (unknown origin) assessed as substrate PHOME hydrolysis after 1 hr by fluorescence method2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID670286Inhibition of CYP3A4 using BFC substrate in which compound added to reaction mixture simultaneously with BFC substrate by fluorometric assay2012Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
C-Aryl 5a-carba-β-d-glucopyranosides as novel sodium glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
AID670287Inhibition of CYP3A4 using BFC substrate in which compound added to reaction mixture before addition of BFC substrate by fluorometric assay2012Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
C-Aryl 5a-carba-β-d-glucopyranosides as novel sodium glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
AID370696Inhibition of human CNT12009Bioorganic & medicinal chemistry letters, Feb-01, Volume: 19, Issue:3
Synthesis and biological evaluation of phloridzin analogs as human concentrative nucleoside transporter 3 (hCNT3) inhibitors.
AID1546222Inhibition of human SGLT12019European journal of medicinal chemistry, Dec-15, Volume: 184Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review.
AID721288Inhibition of tyrosinase (unknown origin) using L-DOPA substrate at 100 uM2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Biocatalytic synthesis, structural elucidation, antioxidant capacity and tyrosinase inhibition activity of long chain fatty acid acylated derivatives of phloridzin and isoquercitrin.
AID418688Inhibition of human kidney SGLT2 assessed as renal glucose reabsorption2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Development of the renal glucose reabsorption inhibitors: a new mechanism for the pharmacotherapy of diabetes mellitus type 2.
AID443605Inhibition of human SGLT1 expressed in HEK293 cells assessed as inhibition of [14C]alpha-methylglucopyranoside uptake2009Journal of medicinal chemistry, Oct-22, Volume: 52, Issue:20
Novel L-xylose derivatives as selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
AID381256Cytotoxicity against human 9KB cells assessed as cell survival at 100 ug/ml relative to control
AID205450Binding affinity against Sodium/glucose co-transporter of isolated renal brush border membranes.2000Journal of medicinal chemistry, May-04, Volume: 43, Issue:9
Probing the conformation of the sugar transport inhibitor phlorizin by 2D-NMR, molecular dynamics studies, and pharmacophore analysis.
AID695397Solubility of the compound in distilled water2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Structure-activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia.
AID1232392Inhibition of monophenolase activity of mushroom tyrosinase using L-tyrosine as substrate at 0.15 mM by spectrophotometric assay2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Identification of p-hydroxybenzyl alcohol, tyrosol, phloretin and its derivate phloridzin as tyrosinase substrates.
AID1436781Inhibition of human SGLT2 expressed in HEK293 cells assessed as reduction in 2-deoxyglucose uptake pretreated for 10 mins followed by 2-deoxyglucose addition in presence of choline buffer measured after 1 hr by resazurin dye based fluorescence assay2017Journal of medicinal chemistry, 01-26, Volume: 60, Issue:2
Targeting Type 2 Diabetes with C-Glucosyl Dihydrochalcones as Selective Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Synthesis and Biological Evaluation.
AID365411Inhibition of human SGLT2 expressed in Xenopus oocyte assessed as [14C]alpha-methyl glucopyranoside uptake2008Bioorganic & medicinal chemistry letters, Sep-01, Volume: 18, Issue:17
Aglycone exploration of C-arylglucoside inhibitors of renal sodium-dependent glucose transporter SGLT2.
AID475686Selectivity ratio of IC50 for human SGLT1 to IC50 for human SGLT22010Journal of medicinal chemistry, Apr-22, Volume: 53, Issue:8
(1S)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-D-glucitol (TS-071) is a potent, selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for type 2 diabetes treatment.
AID1076409Selectivity ratio of IC50 for SGLT1 (unknown origin) to IC50 for SGLT2 (unknown origin)2014Bioorganic & medicinal chemistry letters, Mar-15, Volume: 24, Issue:6
Synthesis of novel l-rhamnose derived acyclic C-nucleosides with substituted 1,2,3-triazole core as potent sodium-glucose co-transporter (SGLT) inhibitors.
AID1436777Inhibition of human SGLT2 expressed in HEK293 cells assessed as reduction in 2-deoxyglucose uptake pretreated for 10 mins followed by 2-deoxyglucose addition in presence of sodium buffer measured after 1 hr by resazurin dye based fluorescence assay2017Journal of medicinal chemistry, 01-26, Volume: 60, Issue:2
Targeting Type 2 Diabetes with C-Glucosyl Dihydrochalcones as Selective Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Synthesis and Biological Evaluation.
AID1464928Inhibition of porcine pancreatic lipase using p-nitrophenyl butyrate as substrate pretreated for 15 mins followed by substrate addition measured after 15 mins in presence of plasma by spectrophotometric method2017Bioorganic & medicinal chemistry letters, 11-01, Volume: 27, Issue:21
Plasma-induced dimerization of phloridzin as a new class of anti-adipogenic agents.
AID1546232Selectivity ratio of IC50 for inhibition of human SGLT1 to IC50 for inhibition of human SGLT22019European journal of medicinal chemistry, Dec-15, Volume: 184Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review.
AID1126475Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production at 0.4 uM after 18 hrs by griess reaction analysis2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID1076411Inhibition of SGLT2 (unknown origin) expressed in HEK293 cells using 2-NBDG as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by nonradioactive fluorescence glucose uptake assay2014Bioorganic & medicinal chemistry letters, Mar-15, Volume: 24, Issue:6
Synthesis of novel l-rhamnose derived acyclic C-nucleosides with substituted 1,2,3-triazole core as potent sodium-glucose co-transporter (SGLT) inhibitors.
AID1436780Inhibition of human SGLT1 expressed in HEK293 cells assessed as reduction in 2-deoxyglucose uptake at 100 uM pretreated for 10 mins followed by 2-deoxyglucose addition in presence of sodium buffer measured after 1 hr by resazurin dye based fluorescence as2017Journal of medicinal chemistry, 01-26, Volume: 60, Issue:2
Targeting Type 2 Diabetes with C-Glucosyl Dihydrochalcones as Selective Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Synthesis and Biological Evaluation.
AID1559420Inhibition of human SGLT2 expressed in Xenopus oocytes assessed as reduction in [14C]AMG uptake after 1 hr by liquid scintillation counting method2020Journal of medicinal chemistry, 04-23, Volume: 63, Issue:8
The Druggability of Solute Carriers.
AID582096Inhibition of single PSAC in erythrocytes infected with Plasmodium falciparum HB3 at 100 to 5000 uM by cell attached patch clamp method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Changes in the plasmodial surface anion channel reduce leupeptin uptake and can confer drug resistance in Plasmodium falciparum-infected erythrocytes.
AID695393Inhibition of rat SGLT2 expressed in COS7 cells assessed as reduction of [14C]-AMG uptake2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Structure-activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia.
AID1076410Inhibition of SGLT1 (unknown origin) expressed in HEK293 cells using 2-NBDG as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by nonradioactive fluorescence glucose uptake assay2014Bioorganic & medicinal chemistry letters, Mar-15, Volume: 24, Issue:6
Synthesis of novel l-rhamnose derived acyclic C-nucleosides with substituted 1,2,3-triazole core as potent sodium-glucose co-transporter (SGLT) inhibitors.
AID779739Inhibition of human SGLT2 expressed in CHO-K1 cells assessed as inhibition of [14C]-AMG uptake up to 120 mins by scintillation counting method2013Bioorganic & medicinal chemistry, Nov-01, Volume: 21, Issue:21
Synthesis and biological evaluation of novel C-aryl d-glucofuranosides as sodium-dependent glucose co-transporter 2 inhibitors.
AID348687Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay2008Bioorganic & medicinal chemistry letters, Sep-15, Volume: 18, Issue:18
Design and synthesis of fluorescent SGLT2 inhibitors.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID695391Selectivity ratio of IC50 for human SGLT2 to IC50 for human SGLT12012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Structure-activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia.
AID1464929Inhibition of porcine pancreatic lipase using p-nitrophenyl butyrate as substrate pretreated for 15 mins followed by substrate addition measured after 15 mins by spectrophotometric method2017Bioorganic & medicinal chemistry letters, 11-01, Volume: 27, Issue:21
Plasma-induced dimerization of phloridzin as a new class of anti-adipogenic agents.
AID1126471Inhibition of sEH (unknown origin) assessed as substrate PHOME hydrolysis at 25 uM after 1 hr by fluorescence method2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID1232389Inhibition of monophenolase activity of mushroom tyrosinase using L-tyrosine as substrate at 0.05 mM by spectrophotometric assay2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Identification of p-hydroxybenzyl alcohol, tyrosol, phloretin and its derivate phloridzin as tyrosinase substrates.
AID386060Inhibition of human SGLT1 expressed in Caco-2 cells assessed as inhibition of methyl-alpha-D-[14C]glucopyranoside uptake at 0.5 mM after 1 hr relative to control2007The Journal of biological chemistry, Sep-28, Volume: 282, Issue:39
Tripeptides of RS1 (RSC1A1) inhibit a monosaccharide-dependent exocytotic pathway of Na+-D-glucose cotransporter SGLT1 with high affinity.
AID378511Inhibition of concanavalin A-induced mouse T cells proliferation assessed as [3H]TdR incorporation at 0.1 uM by MTT assay2005Journal of natural products, Mar, Volume: 68, Issue:3
Dihydrochalcones from the leaves of Pieris japonica.
AID318036Inhibition of human SGLT2 expressed in CHO cells assessed as inhibition of [14C]AMG accumulation2008Journal of medicinal chemistry, Mar-13, Volume: 51, Issue:5
Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
AID295286Inhibition of human SGLT2 expressed in COS1 cells assessed as [14C]methyl-alpha-D-glucopyranoside uptake2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Na+-glucose cotransporter (SGLT) inhibitory flavonoids from the roots of Sophora flavescens.
AID1436776Inhibition of human SGLT1 expressed in HEK293 cells assessed as reduction in 2-deoxyglucose uptake pretreated for 10 mins followed by 2-deoxyglucose addition in presence of sodium buffer measured after 1 hr by resazurin dye based fluorescence assay2017Journal of medicinal chemistry, 01-26, Volume: 60, Issue:2
Targeting Type 2 Diabetes with C-Glucosyl Dihydrochalcones as Selective Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Synthesis and Biological Evaluation.
AID670284Inhibition of human SGLT1 expressed in CHO-K1 cells by [14C]AMG uptake assay2012Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
C-Aryl 5a-carba-β-d-glucopyranosides as novel sodium glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
AID1265118Inhibition of recombinant human N-terminal His6-tagged AKR1B10 expressed in Escherichia coli BL21 cells using all-trans-retinal as substrate at 20 uM incubated for 15 mins by HPLC method2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment.
AID1436774Cytotoxicity in HEK293 cells assessed as cell viability at 100 uM measured after 20 to 24 hrs by Cell-Titer Blue fluorescence assay2017Journal of medicinal chemistry, 01-26, Volume: 60, Issue:2
Targeting Type 2 Diabetes with C-Glucosyl Dihydrochalcones as Selective Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Synthesis and Biological Evaluation.
AID695394Selectivity ratio of IC50 for rat SGLT2 to IC50 for rat SGLT12012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Structure-activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia.
AID1348753Inhibition of human SGLT2 expressed in CHO cells assessed as reduction in [14C]AMG uptake after 1 hr by microbeta counting method2018European journal of medicinal chemistry, Jan-01, Volume: 143Identification of an oxime-containing C-glucosylarene as a potential inhibitor of sodium-dependent glucose co-transporter 2.
AID703960Inhibition of human SGLT2 expressed in CHO cells assessed as inhibition of sodium-dependent [14C]methyl-alpha-D-glucopyranoside uptake after 45 mins2012Journal of medicinal chemistry, Sep-13, Volume: 55, Issue:17
Discovery of tofogliflozin, a novel C-arylglucoside with an O-spiroketal ring system, as a highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
AID703958Selectivity ratio of IC50 for human SGLT1 to IC50 for human SGLT22012Journal of medicinal chemistry, Sep-13, Volume: 55, Issue:17
Discovery of tofogliflozin, a novel C-arylglucoside with an O-spiroketal ring system, as a highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
AID721287Inhibition of tyrosinase (unknown origin) using L-DOPA substrate at 1000 uM2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Biocatalytic synthesis, structural elucidation, antioxidant capacity and tyrosinase inhibition activity of long chain fatty acid acylated derivatives of phloridzin and isoquercitrin.
AID670285Selectivity index, ratio of IC50 for human SGLT1 to IC50 for human SGLT22012Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
C-Aryl 5a-carba-β-d-glucopyranosides as novel sodium glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
AID721292Antioxidant activity assessed as Trolox equivalents of 0.01 mmol/L solution by ORAC assay2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Biocatalytic synthesis, structural elucidation, antioxidant capacity and tyrosinase inhibition activity of long chain fatty acid acylated derivatives of phloridzin and isoquercitrin.
AID554360Selectivity ratio for EC50 for human SGLT1 to EC50 for human SGLT2 expressed in CHO cells assessed as sodium-dependent [14C]-alpha-methyl-D-glucopyranoside uptake after 2 hrs by liquid scintillation counting2011Journal of medicinal chemistry, Jan-13, Volume: 54, Issue:1
Discovery of novel N-β-D-xylosylindole derivatives as sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the management of hyperglycemia in diabetes.
AID295285Inhibition of human SGLT1 expressed in COS1 cells assessed as [14C]methyl-alpha-D-glucopyranoside uptake2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Na+-glucose cotransporter (SGLT) inhibitory flavonoids from the roots of Sophora flavescens.
AID459761Inhibition of human SGLT2 expressed in COS1 cells assessed as [14C]methyl-alpha-D-glucopyranoside uptake at 0.2 uM2010Bioorganic & medicinal chemistry letters, Feb-01, Volume: 20, Issue:3
Cyclic diarylheptanoids as Na+-glucose cotransporter (SGLT) inhibitors from Acer nikoense.
AID582094Inhibition of PSAC-mediated sorbitol uptake in erythrocytes infected with Plasmodium falciparum HB3 at 100 to 5000 uM by osmotic lysis half-time determination assay2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Changes in the plasmodial surface anion channel reduce leupeptin uptake and can confer drug resistance in Plasmodium falciparum-infected erythrocytes.
AID1126479Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion after 18 hrs by sandwich ELISA2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID1292294Selectivity ratio of EC50 for human SGLT1 expressed in CHO-K1 cells to EC50 for human SGLT2 expressed in CHO-K1 cells2016Bioorganic & medicinal chemistry, 05-15, Volume: 24, Issue:10
N-Indolylglycosides bearing modifications at the glucose C6-position as sodium-dependent glucose co-transporter 2 inhibitors.
AID695396Metabolic stability of the compound in rat intestinal microsomes assessed as compound remaining at 50 uM after 60 mins2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Structure-activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia.
AID1348754Inhibition of human SGLT1 expressed in CHO cells assessed as reduction in [14C]AMG uptake after 1 hr by microbeta counting method2018European journal of medicinal chemistry, Jan-01, Volume: 143Identification of an oxime-containing C-glucosylarene as a potential inhibitor of sodium-dependent glucose co-transporter 2.
AID1126477Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion at 0.4 uM after 18 hrs by sandwich ELISA2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID1436779Inhibition of human SGLT2 expressed in HEK293 cells assessed as reduction in 2-deoxyglucose uptake at 100 uM pretreated for 10 mins followed by 2-deoxyglucose addition in presence of sodium buffer measured after 1 hr by resazurin dye based fluorescence as2017Journal of medicinal chemistry, 01-26, Volume: 60, Issue:2
Targeting Type 2 Diabetes with C-Glucosyl Dihydrochalcones as Selective Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Synthesis and Biological Evaluation.
AID1126473Cytotoxicity against mouse RAW264.7 cells assessed as cell viability at 50 uM after 18 hrs by MTT assay in presence of LPS2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID1464930Cytotoxicity against mouse 3T3L1 cells up to 48 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 11-01, Volume: 27, Issue:21
Plasma-induced dimerization of phloridzin as a new class of anti-adipogenic agents.
AID589965Inhibition of SGLT22011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Discovery of non-glucoside SGLT2 inhibitors.
AID695392Inhibition of rat SGLT1 expressed in COS7 cells assessed as reduction of [14C]-AMG uptake2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Structure-activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID365408Inhibition of human SGLT2 expressed in CHO cells assessed as intracellular accumulation of [14C]alpha-methyl glucopyranoside2008Bioorganic & medicinal chemistry letters, Sep-01, Volume: 18, Issue:17
Aglycone exploration of C-arylglucoside inhibitors of renal sodium-dependent glucose transporter SGLT2.
AID721293Antioxidant activity assessed as Trolox equivalents of 1 mmol/L solution by FRAP assay2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Biocatalytic synthesis, structural elucidation, antioxidant capacity and tyrosinase inhibition activity of long chain fatty acid acylated derivatives of phloridzin and isoquercitrin.
AID378513Inhibition of concanavalin A-induced mouse T cells proliferation assessed as [3H]TdR incorporation at 10 uM by MTT assay2005Journal of natural products, Mar, Volume: 68, Issue:3
Dihydrochalcones from the leaves of Pieris japonica.
AID318037Inhibition of human SGLT1 expressed in CHO cells assessed as inhibition of [14C]AMG accumulation2008Journal of medicinal chemistry, Mar-13, Volume: 51, Issue:5
Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
AID695395Metabolic stability of the compound in rat intestinal microsomes assessed as compound remaining at 50 uM after 30 mins2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Structure-activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia.
AID582095Inhibition of PSAC-mediated sorbitol uptake in erythrocytes infected with leupeptin resistant-Plasmodium falciparum HB3-leuR1 by osmotic lysis half-time determination assay2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Changes in the plasmodial surface anion channel reduce leupeptin uptake and can confer drug resistance in Plasmodium falciparum-infected erythrocytes.
AID1126476Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion at 10 uM after 18 hrs by sandwich ELISA2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID443606Selectivity for human SGLT2 over human SGLT12009Journal of medicinal chemistry, Oct-22, Volume: 52, Issue:20
Novel L-xylose derivatives as selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
AID1436784Inhibition of human SGLT1 expressed in HEK293 cells assessed as reduction in 2-deoxyglucose uptake pretreated for 10 mins followed by 2-deoxyglucose addition in presence of choline buffer measured after 1 hr by resazurin dye based fluorescence assay2017Journal of medicinal chemistry, 01-26, Volume: 60, Issue:2
Targeting Type 2 Diabetes with C-Glucosyl Dihydrochalcones as Selective Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Synthesis and Biological Evaluation.
AID589966Inhibition of SGLT12011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Discovery of non-glucoside SGLT2 inhibitors.
AID418689Selectivity for human SGLT2 over human SGLT12009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Development of the renal glucose reabsorption inhibitors: a new mechanism for the pharmacotherapy of diabetes mellitus type 2.
AID614606Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]AMG uptake after 45 mins2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
5a-Carba-β-D-glucopyranose derivatives as novel sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
AID1721968Inhibition of SGLT2 (unknown origin)2020Bioorganic & medicinal chemistry letters, 09-01, Volume: 30, Issue:17
5,5-Difluoro- and 5-Fluoro-5-methyl-hexose-based C-Glucosides as potent and orally bioavailable SGLT1 and SGLT2 dual inhibitors.
AID1205659Inhibition of human CNT2 expressed in COS7 cells assessed as reduction in sodium-dependent [14C]-inosine uptake at 100 uM in presence of Na+ by liquid scintillation counting method2015ACS medicinal chemistry letters, Mar-12, Volume: 6, Issue:3
Identification of 8-aminoadenosine derivatives as a new class of human concentrative nucleoside transporter 2 inhibitors.
AID1546223Inhibition of human SGLT22019European journal of medicinal chemistry, Dec-15, Volume: 184Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review.
AID1721967Inhibition of SGLT1 (unknown origin)2020Bioorganic & medicinal chemistry letters, 09-01, Volume: 30, Issue:17
5,5-Difluoro- and 5-Fluoro-5-methyl-hexose-based C-Glucosides as potent and orally bioavailable SGLT1 and SGLT2 dual inhibitors.
AID365229Selectivity for human SGLT2 over human SGLT1 expressed in CHO cells2008Bioorganic & medicinal chemistry letters, Sep-01, Volume: 18, Issue:17
Aglycone exploration of C-arylglucoside inhibitors of renal sodium-dependent glucose transporter SGLT2.
AID418948Antidiabetic activity in normal Sprague-Dawley rat assessed as urinary glucose excretion at 300 mg/kg, po after 24 hrs2009Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7
Development of the renal glucose reabsorption inhibitors: a new mechanism for the pharmacotherapy of diabetes mellitus type 2.
AID1205660Inhibition of human CNT2 expressed in COS7 cells assessed as reduction in sodium-dependent [14C]-inosine uptake at 1000 uM in presence of Na+ by liquid scintillation counting method2015ACS medicinal chemistry letters, Mar-12, Volume: 6, Issue:3
Identification of 8-aminoadenosine derivatives as a new class of human concentrative nucleoside transporter 2 inhibitors.
AID370697Inhibition of human CNT22009Bioorganic & medicinal chemistry letters, Feb-01, Volume: 19, Issue:3
Synthesis and biological evaluation of phloridzin analogs as human concentrative nucleoside transporter 3 (hCNT3) inhibitors.
AID462408Inhibition of alpha-D-[U-14C]glucopyranoside uptake at human SGLT2 expressed in african green monkey COS1 cells after 30 mins by liquid scintillation counting2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Alstiphyllanines E-H, picraline and ajmaline-type alkaloids from Alstonia macrophylla inhibiting sodium glucose cotransporter.
AID1436778Selectivity ratio of IC50 for human SGLT1 to IC50 for human SGLT22017Journal of medicinal chemistry, 01-26, Volume: 60, Issue:2
Targeting Type 2 Diabetes with C-Glucosyl Dihydrochalcones as Selective Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Synthesis and Biological Evaluation.
AID1126474Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production at 10 uM after 18 hrs by griess reaction analysis2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID641145Inhibition of 14C-U-glucose uptake in rat small intestine at 1 mM after 6 mins relative to control2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Antidiabetogenic oligostilbenoids and 3-ethyl-4-phenyl-3,4-dihydroisocoumarins from the bark of Shorea roxburghii.
AID692014Inhibition of Bacillus stearothermophilus alpha-glucosidase type 42012Journal of natural products, Oct-26, Volume: 75, Issue:10
Dibenzocycloheptanoids from the leaves of Cinnamomum subavenium.
AID378516Inhibition of LPS-induced mouse B cells proliferation assessed as [3H]TdR incorporation at 10 uM by MTT assay2005Journal of natural products, Mar, Volume: 68, Issue:3
Dihydrochalcones from the leaves of Pieris japonica.
AID554362Inhibition of human SGLT1 expressed in CHO cells assessed as sodium-dependent [14C]-alpha-methyl-D-glucopyranoside uptake after 2 hrs by liquid scintillation counting2011Journal of medicinal chemistry, Jan-13, Volume: 54, Issue:1
Discovery of novel N-β-D-xylosylindole derivatives as sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the management of hyperglycemia in diabetes.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID695390Inhibition of human SGLT2 expressed in COS7 cells assessed as reduction of [14C]-AMG uptake2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Structure-activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia.
AID381258Cytotoxicity against human 9KB cells relative to control
AID1232397Inhibition of diphenolase activity of mushroom tyrosinase using L-dopa as substrate at 0.1 mM by spectrophotometric assay2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Identification of p-hydroxybenzyl alcohol, tyrosol, phloretin and its derivate phloridzin as tyrosinase substrates.
AID1232396Inhibition of diphenolase activity of mushroom tyrosinase using L-dopa as substrate at 0.05 mM by spectrophotometric assay2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Identification of p-hydroxybenzyl alcohol, tyrosol, phloretin and its derivate phloridzin as tyrosinase substrates.
AID370698Binding affinity to human recombinant CNT3 expressed in pig PK15NTD cells assessed as [3H]uridine uptake by beta-scintillation counter2009Bioorganic & medicinal chemistry letters, Feb-01, Volume: 19, Issue:3
Synthesis and biological evaluation of phloridzin analogs as human concentrative nucleoside transporter 3 (hCNT3) inhibitors.
AID1808638Inhibition of GLUT1 in African green monkey COS-7 cells assessed as reduction in 2-NBDG uptake at 50 to 100 uM incubated for 90 mins by fluorescence microplate reader analysis2021Journal of medicinal chemistry, 04-22, Volume: 64, Issue:8
Targeting Colorectal Cancer with Conjugates of a Glucose Transporter Inhibitor and 5-Fluorouracil.
AID614607Inhibition of human SGLT1 expressed in CHO cells assessed as [14C]AMG uptake after 45 mins2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
5a-Carba-β-D-glucopyranose derivatives as novel sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
AID670283Inhibition of human SGLT2 expressed in CHO-K1 cells by [14C]AMG uptake assay2012Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
C-Aryl 5a-carba-β-d-glucopyranosides as novel sodium glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
AID1292293Inhibition of human SGLT1 expressed in CHO-K1 cells assessed as reduction in [14C]AMG uptake after 120 mins by scintillation counting method2016Bioorganic & medicinal chemistry, 05-15, Volume: 24, Issue:10
N-Indolylglycosides bearing modifications at the glucose C6-position as sodium-dependent glucose co-transporter 2 inhibitors.
AID721290Inhibition of tyrosinase (unknown origin) using L-DOPA substrate at 10 uM2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Biocatalytic synthesis, structural elucidation, antioxidant capacity and tyrosinase inhibition activity of long chain fatty acid acylated derivatives of phloridzin and isoquercitrin.
AID459760Inhibition of human SGLT1 expressed in COS1 cells assessed as [14C]methyl-alpha-D-glucopyranoside uptake at 0.2 uM2010Bioorganic & medicinal chemistry letters, Feb-01, Volume: 20, Issue:3
Cyclic diarylheptanoids as Na+-glucose cotransporter (SGLT) inhibitors from Acer nikoense.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID381257Cytotoxicity against human 9KB cells assessed as cell survival at 10 ug/ml relative to control
AID1232404Activity at mushroom tyrosinase by spectrophotometric assay in presence of hydrogen peroxide2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Identification of p-hydroxybenzyl alcohol, tyrosol, phloretin and its derivate phloridzin as tyrosinase substrates.
AID365228Selectivity for human SGLT2 over human SGLT1 expressed in Xenopus oocyte2008Bioorganic & medicinal chemistry letters, Sep-01, Volume: 18, Issue:17
Aglycone exploration of C-arylglucoside inhibitors of renal sodium-dependent glucose transporter SGLT2.
AID378514Inhibition of LPS-induced mouse B cells proliferation assessed as [3H]TdR incorporation at 0.1 uM by MTT assay2005Journal of natural products, Mar, Volume: 68, Issue:3
Dihydrochalcones from the leaves of Pieris japonica.
AID695389Inhibition of human SGLT1 expressed in COS7 cells assessed as reduction of [14C]-AMG uptake2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Structure-activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia.
AID614608Selectivity ratio of IC50 for human SGLT1 to IC50 for human SGLT22011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
5a-Carba-β-D-glucopyranose derivatives as novel sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
AID695405Toxicity in Wistar rat assessed as overnight urinary glucose excretion at 10 mg/kg, po2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Structure-activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia.
AID721289Antioxidant activity assessed as DPPH radical scavenging activity2013Bioorganic & medicinal chemistry, Feb-01, Volume: 21, Issue:3
Biocatalytic synthesis, structural elucidation, antioxidant capacity and tyrosinase inhibition activity of long chain fatty acid acylated derivatives of phloridzin and isoquercitrin.
AID378515Inhibition of LPS-induced mouse B cells proliferation assessed as [3H]TdR incorporation at 1 uM by MTT assay2005Journal of natural products, Mar, Volume: 68, Issue:3
Dihydrochalcones from the leaves of Pieris japonica.
AID1232402Activity at mushroom tyrosinase assessed as decrease in absorbance using L-dopa as substrate by oxygen consumption assay2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Identification of p-hydroxybenzyl alcohol, tyrosol, phloretin and its derivate phloridzin as tyrosinase substrates.
AID1348755Selectivity ratio of EC50 for human SGLT1 expressed in CHO cells to EC50 for human SGLT2 expressed in CHO cells2018European journal of medicinal chemistry, Jan-01, Volume: 143Identification of an oxime-containing C-glucosylarene as a potential inhibitor of sodium-dependent glucose co-transporter 2.
AID1232390Inhibition of monophenolase activity of mushroom tyrosinase using L-tyrosine as substrate at 0.1 mM by spectrophotometric assay2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Identification of p-hydroxybenzyl alcohol, tyrosol, phloretin and its derivate phloridzin as tyrosinase substrates.
AID475685Inhibition of human SGLT1 expressed in CHOK1 cells assessed as inhibition of glucose uptake2010Journal of medicinal chemistry, Apr-22, Volume: 53, Issue:8
(1S)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-D-glucitol (TS-071) is a potent, selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for type 2 diabetes treatment.
AID554361Inhibition of human SGLT2 expressed in CHO cells assessed as sodium-dependent [14C]-alpha-methyl-D-glucopyranoside uptake after 2 hrs by liquid scintillation counting2011Journal of medicinal chemistry, Jan-13, Volume: 54, Issue:1
Discovery of novel N-β-D-xylosylindole derivatives as sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the management of hyperglycemia in diabetes.
AID370699Binding affinity to human ENT1 assessed as [3H]uridine uptake by flow cytometry2009Bioorganic & medicinal chemistry letters, Feb-01, Volume: 19, Issue:3
Synthesis and biological evaluation of phloridzin analogs as human concentrative nucleoside transporter 3 (hCNT3) inhibitors.
AID1617647Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as decrease in PGE2 production preincubated for 1 hr followed by LPS stimulation and measured after 24 hrs by ELISA
AID1232403Activity at mushroom tyrosinase assessed as decrease in absorbance using DOMA as substrate by oxygen consumption assay2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Identification of p-hydroxybenzyl alcohol, tyrosol, phloretin and its derivate phloridzin as tyrosinase substrates.
AID1232399Inhibition of diphenolase activity of mushroom tyrosinase using L-dopa as substrate at 0.15 mM by spectrophotometric assay2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Identification of p-hydroxybenzyl alcohol, tyrosol, phloretin and its derivate phloridzin as tyrosinase substrates.
AID582097Inhibition of single PSAC in erythrocytes infected with leupeptin resistant-Plasmodium falciparum HB3-leuR1 cell attached patch clamp method2008Antimicrobial agents and chemotherapy, Jul, Volume: 52, Issue:7
Changes in the plasmodial surface anion channel reduce leupeptin uptake and can confer drug resistance in Plasmodium falciparum-infected erythrocytes.
AID779737Selectivity ratio of EC50 for human SGLT1 expressed in CHO-K1 cells to EC50 for human SGLT2 expressed in CHO-K1 cells2013Bioorganic & medicinal chemistry, Nov-01, Volume: 21, Issue:21
Synthesis and biological evaluation of novel C-aryl d-glucofuranosides as sodium-dependent glucose co-transporter 2 inhibitors.
AID779738Inhibition of human SGLT1 expressed in CHO-K1 cells assessed as inhibition of [14C]-AMG uptake up to 120 mins by scintillation counting method2013Bioorganic & medicinal chemistry, Nov-01, Volume: 21, Issue:21
Synthesis and biological evaluation of novel C-aryl d-glucofuranosides as sodium-dependent glucose co-transporter 2 inhibitors.
AID1292292Inhibition of human SGLT2 expressed in CHO-K1 cells assessed as reduction in [14C]AMG uptake after 120 mins by scintillation counting method2016Bioorganic & medicinal chemistry, 05-15, Volume: 24, Issue:10
N-Indolylglycosides bearing modifications at the glucose C6-position as sodium-dependent glucose co-transporter 2 inhibitors.
AID670288Potency index, ratio of IC50 for CYP3A4 (unknown origin) using BFC substrate in which compound added to reaction mixture simultaneously with BFC substrate to IC50 for CYP3A4 using BFC substrate in which compound added to reaction mixture before addition o2012Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
C-Aryl 5a-carba-β-d-glucopyranosides as novel sodium glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
AID1205658Inhibition of human CNT2 expressed in COS7 cells assessed as reduction in sodium-dependent [14C]-inosine uptake in presence of Na+ by liquid scintillation counting method2015ACS medicinal chemistry letters, Mar-12, Volume: 6, Issue:3
Identification of 8-aminoadenosine derivatives as a new class of human concentrative nucleoside transporter 2 inhibitors.
AID703959Inhibition of human SGLT1 expressed in CHO cells assessed as inhibition of sodium-dependent [14C]methyl-alpha-D-glucopyranoside uptake after 45 mins2012Journal of medicinal chemistry, Sep-13, Volume: 55, Issue:17
Discovery of tofogliflozin, a novel C-arylglucoside with an O-spiroketal ring system, as a highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
AID318038Selectivity for human SGLT2 over human SGLT12008Journal of medicinal chemistry, Mar-13, Volume: 51, Issue:5
Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
AID1798018SGLT Binding Assay from Article 10.1021/jm701272q: \\Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes.\\2008Journal of medicinal chemistry, Mar-13, Volume: 51, Issue:5
Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
AID1347411qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347412qHTS assay to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: Counter screen cell viability and HiBit confirmation2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1346946Human SGLT6 (Sodium myo-inositol cotransporter transporters)2002The Journal of biological chemistry, Sep-20, Volume: 277, Issue:38
Identification of a novel Na+/myo-inositol cotransporter.
AID1346999Human SMIT (Sodium myo-inositol cotransporter transporters)2002The Journal of biological chemistry, Sep-20, Volume: 277, Issue:38
Identification of a novel Na+/myo-inositol cotransporter.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,805)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901022 (56.62)18.7374
1990's263 (14.57)18.2507
2000's195 (10.80)29.6817
2010's243 (13.46)24.3611
2020's82 (4.54)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials8 (0.43%)5.53%
Reviews58 (3.12%)6.00%
Case Studies1 (0.05%)4.05%
Observational0 (0.00%)0.25%
Other1,792 (96.40%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]